FlowPhotoChem partner institutions, the University of Amsterdam, LEITAT and Johnson Matthey, are consortia members in a range of related EU-funded carbon capture research projects. Here, are three of the latest to be funded.

Co2smos (Grant Agreement No. 101000790) is developing a platform of technologies to transform CO2 emissions produced by bio-based industries into a set of high-value-added chemicals with direct use as intermediates for biobased products. Specifically, it will create a toolbox combining intensified chemical conversions (electrocatalytic and membrane reactors) and innovative biotechnological solutions based on gas/liquid combined fermentation processes and organic/green-catalysts reaction processes. The Co2smos will contribute to the sustainability and cost competitiveness of the integrated conversion processes. The University of Amsterdam team is developing an efficient co-electrolysis technology that combines the chemical reduction of CO2 with the production of value-added chemicals. With the Amsterdam-based company Avantium, the academic research group is establishing the novel coelectrolysis concept's technological, economic and environmental viability.

Vivaldi (Grant Agreement No. 101000441) is developing an innovative, sustainable and cost-efficient biotechnological solution to convert off-gas emissions from bio-based Industries into CO2 -based chemicals. In this way, the industry’s greenhouse gas emissions will not only be reduced but will be used as a novel feedstock, lowering the dependency on fossil fuels import and the exploitation of key resources such as energy, raw material, freshwater and land. FlowPhotoChem partner LEITAT Technological Center’s role in VIVALDI is to help develop a Bioelectrochemical System (including selective membranes, reactor design, process optimization and scaling-up) for energy-efficient and selective nutrient recovery from industrial Bio-based Industry wastewater streams from their final use in Pichia pastoris fermentation. LEITAT also participates on the Innovation Board.

CatCo2nvers (Grant Agreement No. 101000580) aims to reduce greenhouse gas emissions from the bio-based industry by developing five innovative and integrated technologies based on three catalytic processes (electrochemical, enzymatic, and thermochemical). The objective is to transform waste-CO2 from two bio-based industries into five added-value chemicals: glyoxylic acid, lactic acid, furan dicarboxylic methyl ester, cyclic carbonated fatty acid methyl esters, and bio-methanol, with application in the chemical, cosmetics, and plastic industries. Our partner Johnson Matthey’s role in CatCo2nvers is through the Johnson Matthey Technology Centre based in the UK. Their main activity is the development of enzymes for lactic acid production from CO2 and bioethanol. JMTC facilities foster the development of new technologies into emerging market applications.

More related research projects are listed on our project website here.